Seamus Mulligan leads $20m funding at medtech Avectas
Drug delivery specialist aims to be key player as medicine turns to cell technology and personalised medicine to tackle cancers
A maverick taking on the Irish whiskey establishment
Waterford Distillery founder Mark Reynier aims to produce the best single malt
Seamus Mulligan leads $10m funding for cell therapy start-up
Avectas has now raised $20m as it looks to unlock potential of personalised medicine
Meet the winning CEOs: Irish Times Business Person of the Month Awards
July, August and September winners of awards in association with KPMG
Business 2018: the winners and the losers
The last 12 months proved to be another year of mixed fortunes in corporate Ireland
Business person of the month: Séamus Mulligan, Adapt Pharma
Adapt agreed a $635m deal in August that will see it taken over by Emergen
What next for Séamus Mulligan?
Entrepreneur might turn attention to Maynooth University cancer therapy spinout
Making millions: how Irish team hit $735m jackpot with overdose rescue drug
US opioid crisis helped growth of overdose rescue drug marketed by Adapt Pharma
Six Irish men to share $635m after sale of drug firm
Adapt Pharma’s Narcan spray used in the front line of opioid crisis in United States
Jazz Pharma slips as it lowers full-year guidance
Irish drug group reports 27% rise in sales but profit slips and supply disruptions remain
Jazz Pharma named as Barclays stock pick for 2017
Drug firm with Athlone manufacturing plant seen as second fastest-growing US share
Diageo sold former Guinness brewery in Waterford for just €7.2m
Company accounts show Waterford Distillers recorded €564,214 loss last year
Jazz Pharma hits all the right notes
Jazz by name and jazzy by metaphor, the Irish firm is now a muscular player in the pharmaceutical world. ‘We specialise in devastating diseases’ says founder Bruce Cozadd
Adapt Pharma invests in Maynooth University tech spin-off
Profector Life Sciences has scientific instruments business selling devices that allow researchers to deliver molecules to cultured cells
Jazz Pharma reports strong second quarter growth
Revenue of $291.2 million, up almost 40 per cent year on year
Séamus Mulligan pumps $86m into new drug venture
Entrepreneur cashes in investment in Jazz Pharmaceuticals to fund new business
Jazz Pharmaceuticals invests €50m in manufacturing plant
Athlone project will create 50 high-skilled full-time jobs when completed by 2016.
Jazz pays $1bn for rare disease drug developer Gentium
Dublin pharma group continues expansion in specialty therapy sector
Jazz Pharma reported to be seeking $757.2m to refinance debt
Advisors for Dublin-based niche drug business hold meeting in New York today
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices